Francesco Marotta – författare

This edited volume studies gut microbiota peculiarities in elderly, in senescence-related  and environmental-related alterations of gut microbiota in chronic diseases. Aging, as a physiological process mediated through several regulatory pathways and transcription factors, is generally speaking associated to a relentless functional decline and increasing risk of chronic diseases. Growing data on gut microbiota quali-quantitative changes in aging gut, and the opportunity to study by advanced NGS and metabolomic technologies, now offers novel horizons to link such changes to disease risks and to theoretically the weapons for gut microbiota intervention as an effective therapeutic tool.

In the wide offer of books on gut microbiota,  this age-thematic volume will be a valuable source of updated information for a wide group of readership including gerontologists, geriatricians, medical specialists of several fields, PhDs, basic scientists and public/private research entities focused on potential intervention in and through  gut ecosystem.

This book will stimulate a large number of basic scientists and clinicians to review their once organ (or cellular line)-specific knowledge and widen either their pathophysiological mechanisms understanding while providing novel ways to prevent, monitor and treat diseases from eyes to bones.

This Volume 1 of a two-volume work provides an up-to-date overview of the latest advances in live biotherapeutics research. It focuses on key areas within probiotics and microbiome studies from the veterinary sciences including their translation into commercial applications.

The book is divided into three sections, comprising (I) fundamentals about probiotic resources, (II) probiotics for veterinary health, with chapters on farm animals, pets, wildlife and aquaculture, and (III) industrial applications of probiotics.

The broad spectrum of industry-relevant contributions makes this work a valuable resource for industry professionals as well as researchers in functional feed and food biotechnology, applied veterinary microbiology and gastroenterology. Presenting novel and evidence-based research, this volume will drive the commercial enterprise and meets the great demand for good probiotic products in the veterinary medical sector.

This Volume 2 of a two-volume work provides an up-to-date overview of the latest advances in live biotherapeutics research, engineered and genome-edited probiotics. It focuses on key areas within probiotics and microbiome studies in human medicine, including their translation into commercial applications.

The book is divided into three sections, comprising (I) biomedical and nutritional benefits of probiotics for human health, (II) post-genomic technologies in probiotics sciences and genome engineering, and (III) biosafety aspects and prospects of biotherapeutics.

The broad spectrum of industry-relevant contributions makes this work a valuable resource for industry professionals as well as researchers in functional food and feed biotechnology, applied microbiology and gastroenterology. Presenting novel and evidence-based research, this volume will drive the commercial enterprise and meets the great demand for good probiotic products in the human medical sector.